anti-IL-17a aptamers (Zenyaku Kogyo/RIBOMIC)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-IL-17a aptamers (Zenyaku Kogyo/RIBOMIC)
Drug Alias Name17M-340
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer
Mechanisms of ActionInterleukin 17A modulators
TargetsInterleukin 17A
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZenyaku Kogyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZenyaku Kogyo Co LtdRibomic Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A